1IA
CVS icon

1620 Investment Advisors’s CVS Health CVS Stock Holding History

1620 Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Buy
2,857
+127
+5% +$11.3K 0.18% 135
2026
Q1 		$196K Buy
2,730
+47
+2% +$3.62K 0.13% 160
2025
Q4 		$213K Sell
2,683
-53
-2% -$4.18K 0.14% 154
2025
Q3 		$206K Buy
2,736
+157
+6% +$10.8K 0.14% 147
2025
Q2 		$178K Buy
2,579
+433
+20% +$28.4K 0.13% 158
2025
Q1 		$145K Sell
2,146
-101
-4% -$6.04K 0.11% 167
2024
Q4 		$101K Sell
2,247
-757
-25% -$42.5K 0.08% 217
2024
Q3 		$189K Sell
3,004
-40
-1% -$2.33K 0.14% 158
2024
Q2 		$180K Sell
3,044
-609
-17% -$38.1K 0.14% 162
2024
Q1 		$291K Sell
3,653
-264
-7% -$20.2K 0.29% 116
2023
Q4 		$309K Buy
3,917
+60
+2% +$4.27K 0.34% 99
2023
Q3 		$269K Buy
3,857
+43
+1% +$3.05K 0.3% 110
2023
Q2 		$264K Buy
3,814
+28
+0.7% +$1.99K 0.29% 111
2023
Q1 		$281K Sell
3,786
-4,654
-55% -$390K 0.34% 100
2022
Q4 		$787K Buy
8,440
+212
+3% +$20.5K 0.95% 35
2022
Q3 		$785K Sell
8,228
-149
-2% -$14.7K 1.16% 26
2022
Q2 		$776K Sell
8,377
-153
-2% -$14.9K 1.07% 25
2022
Q1 		$880K Hold
8,530
– – 0.96% 33
2021
Q4 		$880K Buy
+8,530
New +$788K 0.99% 33

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

1620 Investment Advisors's CVS Position: Q2 2026 in Review

1620 Investment Advisors increased its CVS Health (CVS) stake by 4.7% in Q2 2026, buying an estimated $11.3K and bringing the position to 2,857 shares worth $296K. The position accounts for 0.18% of the portfolio, ranked #135.

1620 Investment Advisors first reported a position in CVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $880K in Q1 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • 1620 Investment Advisors held 2,857 shares of CVS Health worth $296K as of Q2 2026.
  • 1620 Investment Advisors bought 127 CVS Health shares in Q2 2026, an estimated $11.3K.
  • CVS Health made up 0.18% of 1620 Investment Advisors's portfolio in Q2 2026, its #135 holding.
  • 1620 Investment Advisors first reported a position in CVS Health in Q4 2021 and has held it in 19 quarters since.
  • 1620 Investment Advisors's CVS Health position peaked at $880K in Q1 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.